Altimmune, Inc.

UEI
WPSTEWANH2Q8
CAGE
1JRV4
Primary NAICS
541711 Research and Development in Biotechnology
SAM.gov registration
Deleted

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Contracts and Grants
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Website
altimmune.com
Founded
1997
Employees
51-250
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 -$955,970

Contract awards

Award Agency Obligated Awarded
Altimmune - development of a single-dose intranasal vaccine for post-exposure prophylaxis of inhalation anthrax HHSO100201600008C Office of the Assistant Secretary for Preparedness and Response $29,928,823
Vaxin INC. HHSO100201100032C Office of the Assistant Secretary for Preparedness and Response $18,085,644
Purchase Order N0001403M0098 Office of Naval Research (SECNAV) $69,997

Grant awards

Award Agency Obligated Awarded
Development of a simple and effective therapy against post-exposure anthrax R43AI102294 National Institutes of Health $110,701
Acne vaccines targeting a surface sialidase and a secreted camp factor toxin R41AR056169 National Institutes of Health $100,000
Adenovirus vectored vaccines for alzheimer's disease R41AG029768 National Institutes of Health $100,000
In-OVO vaccination/avian influenza/bird/human R44AI068285 National Institutes of Health $952,146

Quick answers

Is Altimmune, Inc. registered in SAM.gov?

Altimmune, Inc.'s SAM.gov registration was deleted on August 22, 2017.

What is Altimmune, Inc.'s CAGE code?

Altimmune, Inc.'s CAGE code is 1JRV4, and its Unique Entity ID (UEI) is WPSTEWANH2Q8.

What is Altimmune, Inc.'s most recent federal award?

Altimmune, Inc.'s most recent federal contract award is Altimmune - development of a single-dose intranasal vaccine for post-exposure prophylaxis of inhalation anthrax (HHSO100201600008C), from Office of the Assistant Secretary for Preparedness and Response, on July 27, 2016.

On GovTribe

See Altimmune, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login

Find teaming partners on GovTribe